NWP-0476 is BCL-2/BCL-xL inhibitor. NWP-0476 has a modified structure with fine-tuned BCL-xL activity. NWP-0476 can be used for relapsed T-acute lymphoblastic leukemia (T-ALL) research[1].
Molecular Weight:
925.49
CAS Number:
[2290611-26-4]
Formula:
C47H53ClN8O8S
Target:
Bcl-2 Family
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted